Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6533
    +0.0010 (+0.15%)
     
  • OIL

    83.83
    +0.26 (+0.31%)
     
  • GOLD

    2,349.20
    +6.70 (+0.29%)
     
  • Bitcoin AUD

    97,571.46
    -1,113.02 (-1.13%)
     
  • CMC Crypto 200

    1,323.84
    -72.70 (-4.99%)
     
  • AUD/EUR

    0.6106
    +0.0033 (+0.54%)
     
  • AUD/NZD

    1.0991
    +0.0034 (+0.31%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,763.28
    +332.77 (+1.91%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • Dow Jones

    38,306.66
    +220.86 (+0.58%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

Regeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Biogen (NASDAQ: BIIB) are developing remarkable therapies that, instead of merely treating disorders, have the potential to cure them or at least make an impact that no other drug has to date. The reason that's not a big cause for alarm is that the company's second-quarter revenue of $2.86 billion would be up 20% over the same period in 2021 if its COVID-19 therapy, REGEN-COV, was excluded from total revenue. The company's sales of the treatment ended late last year when government contracts for the therapy ended.